Erika Jones

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erika Jones:

Company Role Class Num Shares Value Price $ Report Date Ownership
Black Diamond Therapeutics, Inc. Officer Title: Senior Vice President, Finance and Corporate Controller Common Stock 85,150 $212,875 $2.50 30 Jan 2025 Direct
Black Diamond Therapeutics, Inc. Officer Title: Senior Vice President, Finance and Corporate Controller Stock Option (Right to Buy) 200,000 21 Jan 2026 Direct

Insider Reports Filed by Erika Jones

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BDTX Black Diamond Therapeutics, Inc. 21 Jan 2026 1 $0 4 Officer Title: Senior Vice President, Finance and Corporate Controller 23 Jan 2026, 16:05
BDTX Black Diamond Therapeutics, Inc. 30 Jan 2025 2 $0 4 Officer Title: Senior Vice President, Finance and Corporate Controller 31 Jan 2025, 16:35
BDTX Black Diamond Therapeutics, Inc. 14 Feb 2024 1 $0 4 Officer Title: Vice President, Finance and Corporate Controller 15 Feb 2024, 17:34
BDTX Black Diamond Therapeutics, Inc. 13 Feb 2023 2 $0 4 Officer Title: Vice President, Finance and Corporate Controller 15 Feb 2023, 15:11
BDTX Black Diamond Therapeutics, Inc. 15 Feb 2022 2 $0 4 Officer Title: Vice President, Finance and Corporate Controller 17 Feb 2022, 15:17
BDTX Black Diamond Therapeutics, Inc. 18 Nov 2021 0 $0 3 Officer Title: Vice President, Finance and Corporate Controller 29 Nov 2021, 20:25